Pamela Wapnick
Director of Finance/CFO at METAGENOMI, INC.
Net worth: 467 190 $ as of 2024-04-29
Profile
Pamela Wapnick is currently the Chief Financial Officer at Metagenomi, Inc. She has previously worked as Vice President-Finance at Amgen, Inc. and as Chief Financial Officer at Graybug Vision, Inc., True North Therapeutics, Inc., Metagenomi Technologies LLC, and Capsida Biotherapeutics, Inc. She received her undergraduate degree from Wellesley College and her MBA from Columbia Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
METAGENOMI, INC.
0.18% | 2024-03-31 | 69,316 ( 0.18% ) | 467 190 $ | 2024-04-29 |
Pamela Wapnick active positions
| Companies | Position | Start |
|---|---|---|
| METAGENOMI, INC. | Director of Finance/CFO | 2023-08-31 |
Former positions of Pamela Wapnick
| Companies | Position | End |
|---|---|---|
Diality, Inc.
 Diality, Inc. Medical SpecialtiesHealth Technology Diality, Inc. is engaged in manufacturing medical devices. The company is headquartered in Irvine, CA. | Director of Finance/CFO | 2023-08-31 |
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Director of Finance/CFO | 2022-05-31 |
| CALCIMEDICA, INC. | Director of Finance/CFO | 2019-09-30 |
| AMGEN INC. | Director of Finance/CFO | 2016-02-29 |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Director of Finance/CFO | - |
Training of Pamela Wapnick
| Wellesley College | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| METAGENOMI, INC. | Health Technology |
| Private companies | 5 |
|---|---|
Graybug Vision, Inc.
 Graybug Vision, Inc. Pharmaceuticals: MajorHealth Technology Graybug Vision, Inc. develops ophthalmic drugs. It focus on developing drug delivery therapies for the treatment of eye diseases such as age-related macular degeneration and glaucoma. The company was founded by Justin S. Hanes, Peter John McDonnell, Christy Wyskiel and Peter A. Campochiaro in May 2011 and is headquartered in Redwood City, CA. | Health Technology |
Metagenomi Technologies LLC
 Metagenomi Technologies LLC BiotechnologyHealth Technology Metagenomi Technologies LLC engages in the development of curative therapeutics and gene-editing technologies and therapies. The company was founded by Brian C. Thomas in September 2016 and is headquartered in Emeryville, CA. | Health Technology |
Diality, Inc.
Diality, Inc. Medical SpecialtiesHealth Technology Diality, Inc. is engaged in manufacturing medical devices. The company is headquartered in Irvine, CA. | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Capsida Biotherapeutics, Inc. engages in the development of gene therapies for life threatening genetic disorders. It focuses on the provision of adeno-associated virus engineering platform to generate targeted gene therapies. The company is headquartered in Westlake Village, CA. | Commercial Services |
True North Therapeutics, Inc.
True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Pamela Wapnick
